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ABSTRACT 
Objectives: Pyridoxine hydrochloride (PRC) is used in the treatment of side roblastic anemia’s and is also used in a variety of disorders including 
the treatment of depression. Dobutamine Hydrochloride (DOB) is used in the case of congestive heart failure to increase cardiac output and is also 
commonly used in the hospital setting as a pharmacologic stress testing agent to identify coronary artery disease. Linezolid (LZD) is a synthetic 
antibiotic used for the treatment of serious infections caused by gram-positive bacteria that are resistant to several other antibiotics. The main 
objective of our method is to develop a simple, accurate and sensitive spectrophotometric method for the assay of the above mentioned drugs in 
both tablet and pharmaceutical dosage forms. 
Methods: The method is based on the red ox reaction of drugs with Folin Ciocalteu (FC) reagent in sodium carbonate medium and the resulting blue 
colored chromogen is measured at 755 nm. 
Results: Beer’s law is obeyed in the concentration range of 2.5–30 µg/ml (PRC), 1–10 µg/ml (DOB) and 2.5–70 µg/ml (LZD) respectively, with the 
corresponding molar absorptivity values of 7.145 X 103, 3.2080 X 104 and 6.299 X 103 l mol-1 cm-1
Conclusion: The validated method is successfully applied to quantify PRC, DOB and LZD in their commercial formulations with satisfactory results; 
hence the method is suitable for the determination of drugs in bulk and pharmaceuticals. 
. The method is validated for accuracy, precision, 
LOD, LOQ, robustness and ruggedness as per the current ICH guidelines. 
Keywords: Pyridoxine Hydrochloride, Dobutamine Hydrochloride, Linezolid Form-1, Folin Ciocalteu reagent, Spectrophotometry, Pharmaceuticals. 
 
INTRODUCTION 
Pyridoxine Hydrochloride (PRC), chemically (5-hydroxy-6-
methylpyridine-3,4-dimethyl) dimethanol hydrochloride is used in 
the treatment of side roblastic anemia’s; it is readily absorbed from 
the gastrointestinal tract following oral administration and is 
converted to the active forms, Pyridoxal phosphate and 
Pyridoxamine phosphate, which are stored mainly in the liver where 
there is oxidation to 4-pyridoxic acid and other metabolites that are 
excreted in the urine. It is involved in amino acid as well as 
carbohydrate and fat metabolism. It is used in a variety of disorders, 
including the treatment of depression. The survey of literature 
includes the methods are British Pharmacopoeia [1] (BP) (On CD-
ROM: System stimulation Ltd. 3rd ed. London: Stationary office; 
2000), Capillary electrophoresis [2], Zero-crossing [3], Chemi 
luminiscent [4], Derivative spectrophotometric and Differential 
derivative spectrophotometric [5, 6], High performance liquid 
chromatography [7, 8], Spectro fluorimetric and spectro 
photometric [9, 10] and spectrophotometry [11-13]. 
Dobutamine Hydrochloride (DOB), is chemically known as 4-(2-((1-
methyl-3-(4-hydroxybenzene propyl) amido) ethyl-1,2-di-
hydroxybenzene hydrochloric salt is a sympathomimetric with 
direct effects on β1-adrenergic receptors, giving it a prominent 
ionotropic effect on the heart. It also has some α and β2–agonist 
properties. Dobutamine is used in the case of congestive heart 
failure to increase cardiac output. It is indicated when parental 
therapy is necessary for ionotropic support in the short–term 
treatment of patients with cardiac decompensation due to depressed 
contractility, which causes the cardiac disease. The drug is also 
commonly used in the hospital setting as a pharmacologic stress 
testing agent to identify coronary artery disease. 
The literature survey revealed that several analytical methods have been 
reported for the determination of DOB in pure drug, pharmaceutical 
dosage forms and in biological samples. British Pharmacopoeia [14] (BP) 
(Her majesty’s stationary office. 1st ed. London; 2007), Capillary gas 
chromatography [15], voltammetry [16], Chemiluminescence [17], RP-
HPLC [18] and Spectrophotometry [19-21]. 
Linezolid (LZD), chemically (s)-N-[[3-[3-fluoro-4(4-morpholinyl) 
phenyl]-2-oxo-5-azolidinyl] methyl] acetamide was the first 
oxazolidinone to be developed and approved for clinical use. 
Linezolid is a synthetic antibiotic used for the treatment of serious 
infections caused by gram-positive bacteria that are resistant to 
several other antibiotics. Linzolid is active against most gram 
positive bacteria that cause diseases including streptococci, 
vancomycin-resistant enterococci and methicillin-resistant 
staphylococcus auras. The main indication of Linezolid is the 
treatment of severe infections caused by gram-positive bacteria that 
are resistant to other antibiotics; it should not be used against 
bacteria that are sensitive to drugs with a narrower spectrum of 
activity, such as penicillin’s and cephalosporins. The literature 
survey includes British pharmacopeia method [22] (BP) (Her 
majesty’s stationary office. 6th ed. London; 2010. p.410), Capillary 
electrophoresis [23], RP-HPLC [24], Derivative spectrophotometry 
[25], Spectrophotometry [26-28]. 
Visible spectrophotometry is by far the most widely used technique 
for the assay of the mentioned drugs. The above mentioned different 
methods suffer from one or more of the disadvantages such as 
drastic experimental conditions, use of organic solvent, longer 
standing time, poor sensitivity and narrow linear range. Folin 
Ciocalteu (FC) reagent has been widely used for the sensitive 
determination of a wide ranging phenol and amine organic 
compounds of pharmaceutical importance [31-36]. The main 
objective of the present work was to investigate the utility of FC 
reagent in the assay of drugs i.e., PRC, DOB and LZD. The method had 
sufficiently good accuracy and presented a simple and time saving 
assay of the mentioned drugs. The novelty of the method is the 
proposed method is used in drug formulations and also in quality 
control laboratories. The suggested method was further applied for 
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the determination of drugs in commercial pharmaceutical dosage 
forms, which were compared statistically with reference methods by 
means of t-test and F-test and were found not to differ significantly 
at 95% confidence levels. The procedure is characterized by its 
simplicity with accuracy and precision. The structures of studied 
drugs are. 
 
    




MATERIALS AND METHODS 
Apparatus 
A BL 198 Bio spectrophotometer (UV–VIS) with 1.0 cm matched 
quartz cuvettes was used for all absorbance measurements.  
Reagents and solutions 
Chemicals used were of analytical reagent grade. Double distilled 
water was used throughout the experiment. Pyridoxine 
hydrochloride, Dobutamine Hydrochloride (gift sample from Mylon, 
Brazil) and Linezolid (purchased from Cipla Ltd, Bangalore) were 
used as received. 
Stock solutions of each drug containing 100 µg/ml were prepared by 
dissolving 10 mg of the respective drugs in 100 ml of water. The 
solutions were further diluted quantitatively according to their 
linearity range. The pharmaceutical preparations were purchased 
from a local market and analyzed. 
Folin ciocalteu reagent 
Aqueous solution of Folin Ciocalteu reagent (1:1 v/v) was prepared 
by mixing 50 ml of reagent (Merck, Mumbai, India) with 50 ml 
water. 
Sodium carbonate 
A 20% solution of sodium carbonate was prepared by dissolving 20 
g compounds (S. D Fine Chem. Ltd., Mumbai, India) in 100 ml water. 
Procedure for pharmaceutical formulation 
Twenty tablets were weighed and ground into a fine powder. An 
accurately weighed quantity containing 10 mg of drugs (PRC and 
LZD) were transferred to a 100 ml volumetric flask, 60 ml water 
added, shaken well for 20 min and made up to mark with water, and 
then filtered. The solutions were further diluted according to their 
linearity range and analyzed by the recommended procedure. For 
the analysis of an injection (DOB), the requisite amount was 
transferred to a 100 ml volumetric flask and diluted with distilled 
water. The drug content in the diluted solution was determined by 
the recommended procedure.  
Assay procedure 
Into a series of 10 ml volumetric flasks, different aliquots of working 
standard solution of PRC (2.5–30 µg/ml), DOB (1–10 µg/ml) and 
LZD (2.5–80 µg/ml) were transferred to a series of 10 ml volumetric 
flasks. To each flask, 1.0 ml, 1.0 ml and 1.5 ml of 1:1 FC reagent, after 
10 min, 1.0 ml, 1.5 ml and 1.0 ml of 20% sodium carbonate were 
added by means of micro burette.  
The flasks were stoppered and the contents were mixed well and 
kept at room temperature for 10 min. The volume was made up to 
the mark with water and the absorbance of each drug was measured 
at 755 nm against the corresponding reagent blank similarly 
prepared in the absence of drug. 
RESULTS AND DISCUSSION 
Folin Ciocalteu (FC) reagent is specially used for the determination 
of many phenolic compounds utilizing its liability to be reduced 
into blue colored product. Many drug substances such as 
Salbutamol [37], Minocycline [38], Trimetazidine [39], Gliclazide 
[40] and Isoniazid [41] have been determined on this basis. The 
structural features of PRC, DOB and LZD allowed the use of FC 
reagent for its assay.  
The proposed method is based on the formation of a blue colored 
chromogen, following the reduction of phospho molybdo tungstic 
mixed acid of the FC reagent [30] by drugs, in the presence of 
sodium carbonate, which could be measured at 755 nm. The mixed 
acids in the FC reagent are the final chromogen and involve the 
following chemical species:  
3H2O. P2O5. 13WO3. 5MoO3.10H2
3H
O 
2O. P2O5. 14WO3. 4MoO3. 10H2
Drugs probably effects reduction of oxygen atoms from tungstate 
and/or molybdate in the FC reagent, there by producing one or more 
possible reduced species which have characteristic intense blue 
color. The method is based on the red ox reaction of drugs with Folin 
Ciocalteu reagent (FC) in sodium carbonate medium and the 
resulting blue colored chromogen is measured at 755 nm. 
O 
Spectral characteristics 
The intensely blue colored product (molybdenum-tungsten mixed 
acid blue) formed in this method exhibited maximum absorption at 
755 nm. The absorption spectra of the blue colored products against 
the reagent blanks are shown in [fig. 1]. 
Optimization for FC method 
By varying one and keeping the other experimental parameters 
and amount of drug constant, the effect of FC reagent and 
Na 2CO 3 were tested. The maximum color intensity was obtained 
when 1.0–1.2 ml, 0.8–1.0 ml, 1.4–1.6 ml of F-C reagent and 2.8–
3.0 ml, 1.4–1.5 ml, 2.4–2.6 ml of Na 2CO 3  were added to PRC, DOB 
and LZD respectively. The effect of volume of FC reagent and 
Na 2CO 3 for PRC [fig. 2A and 2B], DOB [fig. 3A and 3B], LZD [fig. 
4A and 4B] is as shown below. 
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Fig. 1: Absorption spectra of PRC (10 µg/ml), DOB (6 µg/ml), 
LZD (10 µg/ml) against reagent blank 
 
 
Fig. 2A: Effect of volume of FC reagent (1:1) on the reaction 




Fig. 2B: Effect of 20 % Na2CO3
 
 solution on color formation with 
(10 µg/ml PRC) 
Selection of reaction medium and optimization of the base 
To select a suitable medium for the reaction, different aqueous bases 
such as sodium hydroxide, sodium carbonate or bicarbonate, sodium 
acetate, and sodium hydrogen phosphate were investigated. Better 
results were obtained with 20 % sodium carbonate.  
Maximum color development was obtained in 10 min after mixing 
the reactants, and the color was stable for 12 h. The sequence of 
order of addition of the reactants had the significant effect on the 
absorbance value. So, the order used in the general procedure 
should be followed for maximum absorbance. 
Validation of method 
The method was validated according to the procedures described in 
ICH guidelines (ICH Steering Committee. ICH harmonized tripartite 















Fig. 3A: Effect of volume of FC reagent (1:1) on the reaction 




Fig. 3B: Effect of 20 % Na2CO3
 
 solution on color formation with 
(10 µg/ml DOB) 
 
Fig. 4A: Effect of volume of FC reagent (1:1) on the reaction 
product with LZD (10 µg/ml) in Na2CO3 
 
solution 
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Fig. 4B: Effect of volume of 20 % Na2CO3
Limits of detection (LOD) and Quantification (LOQ) 
 solution on color 
formation with (10 µg/ml LZD) 
The Limits of detection (LOD) and Quantification (LOQ) were 
calculated according to the ICH guidelines using the formulae:  
LOD = 3.3S/b, LOQ = 10S/b, 
Where S is the standard deviation of blank absorbance values and b 
is the slope of the calibration plot. 
Calibration graphs were constructed using standard solutions under 
optimum experimental condition. A linear relationship was 
observed between the absorbance and concentration of drugs from 
(2.5–30 µg/ml), (1–10 µg/ml) and (2.5–70 µg/ml) for PRC, DOB and 
LZD respectively. The molar absorptivity and sandell’s sensitivity for 
each drug were calculated from Beer’s law. Regression analysis of 
beer’s law plots revealed good correlation. The limits of detection 
and limits of quantification were calculated. The sensitivity and 
regression parameters are shown in [table 1]. 
 
Table 1: Sensitivity and regression parameters 
Parameters Optical characteristics 
 PRC DOB LZD 
color blue blue blue 
𝛌𝛌 755 max (nm) 755 755 
Beer’s law limit (µg/ml) 2.5-30 1-10 2.5-70 
Molar absorptivity(l mol-1 cm-1 7.145 X 10) 3.2080 X 103 6.299 X 104 
Sandell’s sensitivity (µg cm
3 
-2 0.0287 ) 0.0015 0.0535 
Limit of Detection [LOD](µg/ml) 0.8783 0.0659 0.5332 
Limit of Quantification [LOQ](µg/ml) 0.2898 0.1999 1.6158 
Regression equation[Y*]    
Slope [B] 0.0251 0.0956 9.507 X 10
Intercept[A] 
-3 
0.1093 0.0384 0.24671 
Correlation coefficient [r] 0.9961 0.9998 0.9980 
Relative standard deviation 0.032 b 0.053 0.088 
*Y= BX+A, where X is the concentration of the measured solution in µg/ml and Y is the unit for absorbance. b
 
Interference 
Average of five determinations 
(concentrations of 7, 5 and 18 µg/ml of pure drugs of PRC, DOB and LZD respectively) 
In order to evaluate the suitability of the proposed method for the 
analysis of pharmaceutical preparations of the studied drugs, the 
interference of associated common excipients such as starch, talc, 
magnesium stearate and lactose were studied. The results indicated 
that none of the excipients studied interfered in quantitative 
analysis by the present method. The results are given in [table 2].
 
Table 2: Recovery of drugs from solutions with a 100 fold concentration of various additives present 
Excipients % aRecovery±% RSD 
 bPRC cDOB dLZD 
Lactose 100.0±0.7 99.9±0.5 100.0±0.6 
Starch 99.8±0.2 100.0±0.6 99.9±0.3 
Talc 99.9±0.3 100.0±0.6 98.9±0.5 
Magnesium stearate 99.5±0.5 99.8±0.4 99.6±0.2 
a mean±RSD, n=3, a mean of three determinations, b concentration of PRC used–15 µg/ml, c concentration of DOB used–5 µg/ml, d 
 
Precision and accuracy 
concentration of 
LZD used–20 µg/ml 
The intraday precision (short term precision) of the drugs were 
analyzed by measuring the 5 independent samples at three different 
concentration levels (5, 15, 20 µg/ml) for PRC, (2, 4, 6 µg/ml) for 
DOB and (20, 40, 60 µg/ml) for LZD. Similarly the inter day precision 
(daily precision) was evaluated at the same concentration on five 
consecutive days (n = 5). The results are shown in [Table 3]. In order 
to check the validity of the proposed method, PRC, DOB and LZD 
were determined in some commercial formulations [Table 4] gives 
the results of the determination from which it is clear that there is 
no close agreement between the results obtained by the proposed 
methods and the label claim. The results were also compared 
statistically by a student’s t-test for accuracy and variance ratio F-
test for precision with those of the standard methods (BP method) 
at 95% confidence level. The calculated t-and F-values [Table 4] did 
not exceed the tabulated values (t = 2.44, F = 5.05) and indicated 
that there is no significant difference between the proposed method 
and the standard method. 
The accuracy and validity of the proposed method was further 
ascertained by performing recovery studies. Pre-analyzed samples 
were spiked with pure drugs at three different levels and the total 
volume was found by the proposed method. Each determination was 
repeated five times. The recovery of the pure drug added was 
quantitative and co-formulated substances starch, talc, magnesium 
stearate and lactose did not interfere in the determination. The 
results of recovery study are compiled in [table 5]. 
Papanna et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 8, 151-156 
155 
Table 3: Evaluation of intraday and interday accuracy and precision 
Formulation bAmount taken (µg/ml) a
(µg/ml) 
Amount found Intraday 
% Recovery±% RSD 
 Interday 
% Recovery±% RSD 
 
PRC 
5.0 4.99 99.8±2.41 99.9±2.32 
15.0 15.01 100.0±0.58 100.01±0.60 
20.0 19.98 99.99±0.55 100.0±0.57 
 
DOB 
2.0 1.98 99.0±2.1 99.6±2.3 
4.0 4.02 100.5±1.0 100.02±0.90 
6.0 5.99 99.8±0.39 99.99±0.41 
 
LZD 
20.0 20.01 100.05±0.94 99.99±0.85 
40.0 39.98 99.95±0.48 98.98±0.40 
60.0 59.99 99.98±0.37 99.8±0.31 
a
 
 Mean value of five determinations 
Table 4: Analysis of drugs in pharmaceutical formulations 
Drug formulations  Label claimed % Recovery±sd 
aProposed method *Reference method (BP) 
 Benadon, tab 







Dobier S, inj 















*Mean of five determinations±Standard deviation(sd) n=5; the t-and F-values obtained after comparison to the reference methods, which have the 
following theoretical values at 95% confidence limit t=2.44 and F=5.05. 
 
Table 5: Results of recovery experiments by standard addition method 
Formulation studied Amount of drug taken in, µg Amount of pure drug added, µg *Total found, µg %Recovery±%RSD 
 
Benadon (40 mg) 
5.0 2.5 7.52 100.2±1.23 
5.0 7.5 12.49 99.9±0.75 
5.0 12.5 17.51 100.0±2.74 
 
Dobier S(250 mg) 
2.0 1.0 3.16 105.3±0.82 
2.0 4.0 5.98 99.6±0.38 
2.0 7.0 9.11 101.2±0.35 
 
Alzolid (600 mg) 
20.0 10.0 30.02 100.0±0.49 
20.0 30.0 49.91 99.8±0.48 
20.0 50.0 69.96 99.9±0.48 
* Mean value of five determinations 
 
Robustness and ruggedness 
Method robustness was studied by making small changes in the 
optimized experimental variables and their effect on the absorbance 
was evaluated by calculating the percentage RSD values. In order, to 
determine the method ruggedness, analyses were performed using 
three instruments and also by three analysts with the same 
instrument. 
CONCLUSION 
A simple, rapid, selective and sensitive method has been 
proposed for the assay of drugs and in pharmaceutical 
formulations. The method is based on the well-characterized and 
established red ox reaction and uses very common and 
inexpensive chemicals and easily accessible instrument.  
The method is applied successfully to the assay of drugs in 
tablets and injection without interferences from the common 
excipients. The proposed method is suitable for PRC, DOB and 
LZD determination in bulk drug and pharmaceuticals; hence this 
method can be used in quality control laboratories. 
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